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Background:  A few study reported the safety and efficacy of catheter ablation of atrial fibrillation (AF) in left atrium (LA) in patient with prosthetic 
mechanical mitral valve (MMV).
Methods:  64 patients with MMV who underwent ablation for either persistent (N=48) or paroxysmal (N=16) were included. Anti-arrhythmic drugs 
(AADs) were stopped five half-lives before ablation but patients were kept on warfarin with remaining INR in therapeutic range. Transseptal puncture 
was guided by intracardiac echocardiography. Conventional and electroanatomical (CARTO) mapping were applied. Radiofrequency energy was 
delivered with a 3.5mm open irrigated-tip catheter. Pulmonary vein antra isolation (PVAI) was performed. This was extended to the entire posterior 
wall down to the coronary sinus and to the LA septum when necessary. Complex fractionated electrograms and LA appendage were also targeted 
when required. After sinus rhythm (SR) was restored, a challenge with isoproterenol infusion up to 30μg/min was performed and ectopic atrial beats 
or tachycardias (trigger activities) arising from extra-PV foci were abolished. The endpoint of procedure was complete PVAI as well as elimination of 
all potential trigger sites. Patients were closely followed-up by ECGs, transtelephonic monitoring, 7-day Holters and office visit.
Results:  All patients (19 males; age 61±11yrs) underwent the procedure successfully. They had enlarged LA (49.7±11mm) but fairly normal 
cardiac function (EF 50.0±11%). INR on the day of ablation was 2.5±0.7. There were 2 groin hematomas and 1 pericardial effusion requiring 
intervention. All except one patient had extra-PV triggers. 16 patients had the 2nd procedure. After 27±4 months follow up, 39 (61%) patients were 
in SR off AAD with a single procedure; while with more than one procedure 58 (92%) patients remained SR off AAD. Late recurrence was observed 
in 8 (12%) patients and consisted of focal atrial tachycardia in 3 and atypical atrial flutter in 5 patients. All were treated successfully with repeat 
ablation.
Conclusions:  Catheter ablation inside the LA in patients with MMR is feasible and safe.
